System Improvement for Severe Stroke Care
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to enhance the emergency care system for severe stroke patients, similar to trauma systems. It focuses on patients with large vessel occlusion (LVO), a type of stroke that blocks major blood vessels in the brain. The trial seeks to improve access to mechanical thrombectomy (MT)—a procedure that can significantly benefit LVO patients—by coordinating care across different regions. Individuals who may qualify have had a suspected severe stroke and were entered into Alabama's stroke system by emergency medical services (EMS). As an unphased trial, this study offers the opportunity to contribute to groundbreaking research that could transform stroke care systems.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Why are researchers excited about this trial?
Researchers are excited about the STROKE STAT trial because it aims to improve how quickly severe stroke patients receive treatment. Unlike traditional methods, which often involve a one-size-fits-all approach, this trial explores triaging patients based on stroke severity to speed up critical interventions like clot removal or clot-busting drugs. The hope is that by tailoring the response to the stroke's severity, patients will receive faster and more effective care, potentially improving outcomes and reducing long-term disabilities.
Who Is on the Research Team?
Toby Gropen, MD
Principal Investigator
UAB Neurology
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Period
All stroke patients undergo standard triage to the nearest stroke center of any level
Implementation Period
Implementation of TCC Coordinated SBST where patients are routed to MTCs based on severity and transport time limits
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- No Intervention
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
patients with suspected severe acute stroke
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.